The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Azathioprine in Behçet's syndrome. Effects on long‐term prognosis
Abstract
Objective. To assess the effect of azathioprine (AZA) treatment on long‐term prognosis in Behçet's syndrome. Methods. Patients (all male) who took part in a double‐blind, placebo‐controlled trial of AZA a mean ± SD of 94 ± 10 months previously were reevaluated. Results. The emergence of blindness (log rank χ 2 = 5.6, P = 0.02) and a 2‐line drop in the visual acuity of the right eye (log rank χ 2 = 5.9, P = 0.015) occurred significantly more frequently among the patients originally allocated to the placebo group compared with patients who originally received AZA, despite posttrial treatment for patients in both groups when needed. There was also a trend toward more frequent occurrence of extraocular complications in the placebo group. The beneficial effect of AZA was especially pronounced among patients who had eye involvement of short duration prior to their entry into the trial. Conclusion. Early treatment with AZA tends to favorably affect the long‐term prognosis of Behçet's syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Controlled Trial of Azathioprine in Behçet's Syndrome
Yazici, H., Pazarli, H., Barnes, C. G., Tüzün, Y., Özyazgan, Y., Silman, A., Serdaroğlu, S., Oğuz, V., Yurdakul, S., Lovatt, G. E., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002013220501 · Cited by 647
Self-citationMasuda, K., Urayama, A., Kogure, M., Nakajima, A., Nakae, K., & Inaba, G. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92381-7 · Cited by 490
Yazici, H., Tüzün, Y., Pazarli, H., Yurdakul, S., Ozyazgan, Y., Ozdoğan, H., Serdaroğlu, S., Ersanli, M., Ulkü, B. Y., & Müftüoğlu, A. U. (1984) · Annals of the Rheumatic Diseases · doi:10.1136/ard.43.6.783 · Cited by 411
Self-citationUSES AND ABUSES OF CHLORMETHIAZOLE
Exton-Smith, A. N., Mclean, A. E. M., Majumdar, S., Glatt, M. M., & Scott, C. J. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92998-2 · Cited by 309
The Rate of Visual Loss in Behcet's Disease
Mamo, J. G. (1970) · Archives of Ophthalmology · doi:10.1001/archopht.1970.00990040453009 · Cited by 128
Cited by
Sakane, T., Takeno, M., Suzuki, N., & Inaba, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910213411707 · Cited by 1,594
Kural-Seyahi, E., Fresko, I., Seyahi, N., Ozyazgan, Y., Mat, C., Hamuryudan, V., Yurdakul, S., & Yazici, H. (2003) · Medicine · doi:10.1097/00005792-200301000-00006 · Cited by 768
Self-citationEULAR recommendations for the management of Behçet disease
Hatemi, G., Silman, A., Bang, D., Bodaghi, B., Chamberlain, A. M., Gul, A., Houman, M. H., Kötter, I., Olivieri, I., Salvarani, C., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.080432 · Cited by 718
Self-citationUveitis in Behçet disease: An analysis of 880 patients
Tugal-Tutkun, I., Onal, S., Altan-Yaycioglu, R., Huseyin Altunbas, H., & Urgancioglu, M. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.03.022 · Cited by 631
Current Concepts in the Etiology and Treatment of Behçet Disease
Evereklioglu, C. (2005) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2005.04.009 · Cited by 393
Metadata
- Authors
- Hamuryudan, V., Özyazgan, Y., Hizli, N., Mat, C., Yurdakul, S., Tüzün, Y., Şlenocak, M., & Yazici, H.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1997-04
- Volume
- 40
- Issue
- 4
- Pages
- 769-774
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2156195056
- Cited by
- 280
- References
- 5
- FWCI
- 13.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.